Why Your Neuropathy Machine Didn’t Work — A Naperville Neuropathy Specialist Explains

You did the sessions. Maybe six weeks, maybe twelve. Pads on your feet, or your feet in a warm water bath, or under a panel of red lights. It felt pleasant. Sometimes you walked out feeling looser. And a month after the program ended, your feet were exactly where they’d been before you started.

At some point you stop wondering whether the treatment failed and start wondering whether anyone actually knows what they’re doing.

Here’s what I want you to know before you spend money on anything else. In most cases the problem wasn’t that “those machines don’t work.” It’s that there are at least seven completely different categories of device being sold for neuropathy — they work by entirely different mechanisms, some of them aren’t electrical at all, and almost nobody tells you which one you’re getting.

I’m Dr. Jennifer Wise, DC, Acupuncturist, and I’ve treated peripheral neuropathy in Naperville since 2000. In 2010 I trained directly with Dr. John Hayes Jr. through the NeuropathyDR program — that’s where I realized neuropathy needed more than what I had. I’ve been testing and refining ever since, and I still am: laser training, shockwave training, molecular hydrogen certification through the Molecular Hydrogen Institute, and now the Neurogenx 4000Pro. Every technology in this article, I’ve either used or evaluated. For a long time none of it fully checked the box. That changed. If you’re looking for the best neuropathy treatment in Naperville, or a neuropathy specialist near me, this article will help you figure out what you already tried before you try anything else.

Synergy Institute Acupuncture & Chiropractic is a peripheral neuropathy treatment clinic located in Naperville, Illinois, conveniently located on Illinois Rte 59 near the 111th Street intersection, serving patients from Aurora, Plainfield, Bolingbrook, Oswego, Lisle, and Woodridge.

What lets me sort these devices honestly isn’t that I own several. It’s the training underneath. I’m a Palmer College graduate and an acupuncturist, and both backgrounds shape how I evaluate any nerve treatment — chiropractic training means I look for the structural contributor before assuming a case is metabolic, and sixteen years of acupuncture practice means I’ve worked with circulation and nerve modulation directly. Only after that assessment do the advanced technologies come into it: the Neurogenx 4000Pro, Stimpod NMS460, ARPwave, SoftWave, and MLS laser.

A 2024 systematic review and meta-analysis covering 30 studies of transcutaneous electrical nerve stimulation for neuropathic pain found TENS produced only a small reduction in pain compared with placebo — a difference that was not clinically significant. For diabetic neuropathic pain specifically, TENS performed similarly to placebo and to other electrotherapies.

Our approach to neuropathy treatment: we identify which specific mechanism is driving your nerve damage — metabolic, nutritional, toxic, circulatory, or structural — correct the underlying cellular conditions that caused the nerve to stop functioning, and then use targeted bioelectric technology matched to that diagnosis, rather than applying one device to everyone and hoping.

Looking for neuropathy relief in Naperville? Call or text (630) 454-1300 to schedule your evaluation.

Direct Answer: What You Probably Had

Devices sold for neuropathy fall into seven electrical categories plus a group of therapies that aren’t electrical at all. Low-frequency devices (TENS, ReBuilder, roughly 100–400 Hz and below) block pain signals at the surface. Mid-frequency devices (interferential current, around 4,000 Hz) reach moderate depth. High-frequency electroanalgesia (Neurogenx at 400–60,000 Hz, Sanexas at 4,000–20,000 Hz, NeuroMed Matrix at 8,000–10,000 Hz) is aimed at the cell rather than the signal. Direct current neuromuscular stimulation (ARPwave, Neubie) re-educates movement patterns. Pulsed radiofrequency (Stimpod tPRF) targets specific nerve pathways. Microcurrent (Frequency Specific Microcurrent, Alpha-Stim) operates below the threshold you can feel, and signal substitution (Calmare) overwrites pain information. And light and magnetic therapies — Anodyne infrared, red light, cold laser, PEMF — are not electrotherapy at all, though patients almost always believe they are. In my experience, many people who conclude “the machine didn’t work” received a low-frequency device or a light therapy.

Does This Sound Like You?

• You had “electrical treatment” but nobody told you the brand or the frequency
• There’s a device in your closet you stopped using
• You did a program with a branded name you couldn’t find anything about online
• You were told it was FDA-approved
• You bought something advertised on social media that goes under your feet
• You tried “the light thing” and aren’t sure whether it was laser, infrared, or red light
• You felt better during sessions and back to baseline within weeks of finishing
• You’ve decided none of this works and you’re only reading this out of stubbornness

That last one is the person I most want to reach.

Why Nobody Can Tell These Apart

Patients call all of it “the nerve machine.” Clinics rarely correct them, because vagueness sells better than specifics.

Here’s the problem underneath. A forty-dollar drugstore TENS unit and a clinical device costing tens of thousands both involve pads on your skin and a tingling sensation. During the session they can feel similar. The difference isn’t in what you feel — it’s in what current is being delivered, at what frequency, how deep it penetrates, and whether the mechanism is blocking a signal or acting on the cell.

Tissue impedance is the physics underneath most of it. Human tissue resists electrical current, and that resistance falls as frequency rises. Low-frequency current disperses in surface tissue. Higher-frequency current passes deeper. Frequency isn’t a specification detail on a brochure — it determines what the treatment can physically reach.

And small fiber nerve damage, the kind responsible for burning feet in diabetic and chemotherapy-induced neuropathy, is not at the surface.

If you’ve been carrying around the belief that you already tried this and it failed, stay with me. There’s a good chance you tried one narrow slice of it.

Category 1: Low-Frequency Electrotherapy (Pain Gating)

Typical range: roughly 100 to 400 Hz and below. Examples: standard TENS, ReBuilder (7.83 Hz), H-Wave, and the consumer units sold online — foot pads advertised on social media and similar.

This is the largest category by far, and it’s what most people who say “electrotherapy didn’t work for my neuropathy” actually received.

TENS works through pain gating — flooding the nerve pathway with sensory input that competes with pain signals for transmission to the brain, plus some endorphin release. That’s a real mechanism, and TENS is legitimately useful for musculoskeletal pain. But understand what it’s doing: changing your perception of a signal. Its primary role is symptom modulation rather than nerve regeneration. Turn it off, and the pain-relieving effect generally fades.

The foot pads advertised heavily on social media are TENS units with different marketing. If it cost under two hundred dollars and arrived in the mail, that’s what you have.

The ReBuilder deserves a fairer hearing than the rest, and I say that as someone who used it in practice for years. I was trained on it in 2010 as part of the NeuropathyDR program. It runs at 7.83 Hz and combines nerve stimulation with muscle stimulation that drives the venous pump in the calves, improving circulation to the lower legs. Patients got relief. The design thinking was sound.

The limitation showed itself over time. At 7.83 Hz, tissue impedance is high and current disperses superficially. You get comfortable symptom modulation and better circulation — worth something — but you aren’t delivering meaningful energy to the small fibers deep in the tissue. Low-frequency devices produce relief. They rarely produce recovery. That’s why I moved on.

Category 2: Mid-Frequency Electrotherapy

Typical range: 1,000 to 12,000 Hz. Examples: interferential current (4,000 Hz carrier), Russian stimulation, NMES, Dynatron-class devices.

Common in physical therapy clinics and chiropractic offices. Interferential current uses two crossing mid-frequency currents that interfere with each other to produce a lower-frequency effect at depth, getting past the skin’s resistance more comfortably than direct low-frequency current can.

These reach moderate depth and produce some cellular effect. Good tools for musculoskeletal pain, muscle re-education, and circulation. For nerve regeneration in peripheral neuropathy, supportive at best.

We use a mid-frequency modality in our clinic as a selective adjunct for cases needing extra help with circulation and the tissue environment. It supports cellular function, circulation, and the tissue environment. It is not what restores nerve signaling.

Category 3: High-Frequency Electroanalgesia

Typical range: 400 to 60,000 Hz. This is where the serious neuropathy devices live — and where the differences actually matter.

Three devices dominate this category. The NeuroMed Matrix runs 8,000–10,000 Hz and has the widest clinic adoption, delivered through adhesive pads or conductive sock and glove garments. Sanexas neoGEN runs 4,000–20,000 Hz and has the most published research of the group. Both are FDA-cleared, both are legitimate, and I’m not going to pretend otherwise to make a point about the one I chose.

But there’s something you should know about how these get sold. The NeuroMed Matrix is widely licensed, available to any clinic, and sold used on medical equipment marketplaces. It’s the device behind several nationally marketed “proprietary” neuropathy protocols — trademarked program names, invented acronyms, a machine that never gets named. When a program won’t tell you what’s in the room, this is frequently what’s inside.

What high-frequency electroanalgesia actually does

Before the comparison, understand what separates this whole category from Categories 1 and 2 — because the mechanism is genuinely different, not just stronger.

Low-frequency devices work on the signal. They interrupt pain transmission on its way to your brain. The nerve itself is unchanged.

High-frequency electroanalgesia is aimed at the cell. At these frequencies the current passes into deep tissue and interacts with nerve cell membranes directly. Four things are proposed to happen. Sustained depolarization — the membrane is held open longer than a brief pulse allows, which is thought to let the cell take in energy and begin repair. Metabolic activation — cellular metabolism increases in tissue that has been running on a deficit, sometimes for years. pH normalization — damaged, inflamed tissue turns acidic, and the electrical field helps shift it back toward a range where cells can function. Fluid and waste mobilization — the alternating field moves charged molecules, helping clear accumulated interstitial fluid, hydrogen ions, and metabolic waste that have been sitting around a struggling nerve.

That last effect is why some patients notice their feet feel less “full” or less swollen early on, before any change in sensation. These mechanisms come from bench research rather than large clinical trials — but they’re the reason the category exists, and they’re a different premise entirely from blocking a pain signal.

Whether that produces recovery in your particular case depends on the drivers underneath — which is the point of the section further down.

Why we chose the Neurogenx 4000Pro

The Neurogenx 4000Pro with NervePro 2.0 is a different animal, and I want to be specific about why rather than just asserting it.

The range, not just the ceiling. Neurogenx spans 400 to 60,000 Hz — three times the top frequency of Sanexas and six times the NeuroMed Matrix. But the number that matters more is the span. A device locked into an 8,000–10,000 Hz window treats every patient in that window, every session, regardless of what’s in front of it. Neurogenx covers a much broader therapeutic frequency range, which means treatment can be tuned to tissue depth, nerve type, and where you are in recovery. A patient with dense numbness in the forefoot and a patient with burning that starts at the ankle are not the same problem, and they shouldn’t get the same parameters. Nobody has run a head-to-head trial comparing adjustable range against fixed-band devices — but that adjustability is why I chose this one.

The waveform. This is the part most comparisons miss entirely, and it may matter more than the frequency.

Most electrotherapy devices deliver a square wave or a sine wave — clean, easy to generate electronically, and a signal your nerve cells have never encountered in nature. A real nerve impulse has a specific asymmetric shape: rapid depolarization, a sharper repolarization, a brief undershoot. That shape is what cell membranes evolved to respond to.

Neurogenx uses what’s called a biosimilar waveform, patterned after the actual nerve action potential. The premise is that a signal shaped like the body’s own signaling interacts with membrane channels more effectively than a generic one. That’s a design philosophy rather than a spec-sheet number, and it’s proprietary to the technology. It’s also the reason the device can’t simply be swapped for a cheaper unit running similar frequencies.

The technology has a lineage. Neurogenx isn’t a device that appeared with a marketing campaign. The underlying electroanalgesia technology traces back through Synaptic Corporation’s work on electric cell signaling, transitioned into the current Neurogenx platform in 2017, and the 4000Pro with NervePro 2.0 is the current generation. You can trace where it came from. That’s not true of every device being sold for neuropathy.

Delivery matters too. Neurogenx uses adhesive electrode placement selected by the treating doctor based on where your symptoms and your nerve distribution actually are. Conductive sock and glove systems — used by other devices in this category — are convenient and patient-friendly, but they deliver the same field to everyone’s foot. Electrode placement is a clinical decision, and I make it.

It isn’t a commodity device. You can’t buy a Neurogenx used, rebrand it, and market it as your own invented protocol. That constrains how many clinics have one — which is why we’re the first and only provider in Naperville — but it also means that when you see the name, you know exactly what you’re getting.

The evidence I find most persuasive is structural. Pre- and post-treatment skin biopsies from Neurogenx patients, processed by independent pathology laboratories including Bako Pathology Services and Advanced Laboratory Services, have shown epidermal nerve fiber density increases ranging from 42% to over 700%.

That deserves a moment, because it’s a different kind of evidence than most of what gets cited in this field. Epidermal nerve fiber density is measured on a punch skin biopsy — a small sample of skin, stained and examined under a microscope, with the small nerve fibers counted. It’s the gold-standard test for small fiber neuropathy, and it’s why a normal nerve conduction study doesn’t rule out nerve damage. Standard EMG measures large fibers. The small fibers responsible for burning and temperature sense don’t show up on it at all.

So when nerve fiber density increases on biopsy, that’s not a patient reporting they feel better. That’s more nerve fibers physically present in the tissue than there were before. This is compiled case data from treating clinics rather than a randomized controlled trial — but the laboratories doing the measuring had no stake in the result.

What a session is actually like. Adhesive electrodes are placed on the treatment area — usually feet and lower legs, or hands and forearms. Sessions run about 25 to 50 minutes. Most patients describe a mild tingling or warmth and find it relaxing; a fair number fall asleep. No needles, no medication, no recovery time, and you drive yourself home.

I chose Neurogenx on mechanism, on range, on the waveform design, and on the biopsy data. Not because a company handed me a number.

If you’re in Naperville and you’ve tried a device that didn’t help, call or text (630) 454-1300 — bring it with you.

Category 4: Direct Current Neuromuscular Stimulation

Examples: ARPwave (up to 500 Hz, newer units to 1000 Hz), Neubie (up to 250 Hz).

These break the frequency framework entirely, because they use direct current rather than alternating current. Don’t compare their numbers to the devices above — a DC device at 500 Hz isn’t a weaker version of an AC device at 60,000 Hz. Different current, different target, different job.

Here’s the part that actually distinguishes them: you move during treatment. Direct current is applied while you’re going through movement patterns, and that’s the point — it’s re-educating how muscles fire and how you move, not stimulating tissue while you lie there. That makes it the right tool for the downstream problems neuropathy leaves behind: weakness, altered gait, muscles that stopped recruiting properly, balance that never came back.

Between the two, the difference is output ceiling. Neubie reaches 250 Hz; ARPwave reaches 500, with newer units going to 1000. Our clinic runs a 500. That headroom matters with deconditioned tissue or someone who’s been compensating for years.

If you had either of these, you had motor re-education. Not nerve regeneration. Both matter, and they aren’t the same job.

Category 5: Pulsed Radiofrequency Neuromodulation

Example: Stimpod NMS460 (tPRF).

Another different axis. Stimpod NMS460 delivers pulsed radiofrequency to a specific nerve pathway. The goal isn’t broad tissue penetration — it’s interrupting an established pattern of wrong signaling in a nerve that has learned to misfire. Entrenched neuropathic pain, post-surgical nerve pain, nerves that keep firing wrong long after the original insult.

We were the first Stimpod provider in Illinois, in October 2025.

Here’s why this matters: Stimpod isn’t a weaker or stronger version of Neurogenx. Different job. A clinic with one device will tell you their device does everything.

Category 6: Microcurrent

Examples: Frequency Specific Microcurrent, Alpha-Stim, Electro-Acuscope, Myopulse.

Microcurrent runs at millionths of an amp — below the threshold you can feel. The premise is entirely different from everything above: rather than stimulating nerve or muscle tissue, microcurrent is proposed to work at the level of cellular signaling and ATP production.

We’ve had Frequency Specific Microcurrent in the clinic since 2005. Useful tool with a real evidence base for certain applications, particularly some pain and inflammatory conditions.

If you had microcurrent and felt nothing during the session, that’s expected. That’s the design, not a malfunction.

Category 7: Signal Substitution

Example: Calmare / Scrambler Therapy (MC-5A).

Nobody in the Naperville area offers this. I’m including it because patients ask, and because it’s a legitimate technology.

Calmare doesn’t try to reach deeper tissue or restore cellular function. It transmits synthetic “non-pain” information along the same nerve pathway carrying the pain signal, effectively overwriting the message reaching your brain. There’s published research supporting it, particularly for chemotherapy-induced peripheral neuropathy.

It’s analgesic, not regenerative. It manages pain — genuinely, for some patients — without changing the underlying nerve damage. If your primary problem is severe intractable neuropathic pain rather than numbness or loss of function, it’s worth knowing this exists.

A note on implanted neurostimulators. Implanted neurostimulators are sometimes offered for intractable nerve pain. These do use electrical stimulation — but permanently implanted, placed surgically, with the risks any implant carries. And the goal is different: they suppress or block the pain signal so you feel it less. They aren’t healing the nerve. For some patients with severe pain who’ve exhausted conservative options, that trade is worth making. But it’s a decision that belongs after conservative care has been tried, not before — and once hardware is in, you’ve chosen a different path.

These Aren’t Electrotherapy At All

Here’s what most people don’t realize: several of the most common “neuropathy machines” don’t involve electrical current passing through tissue at all.

Anodyne / monochromatic infrared energy (MIRE). If you had neuropathy treatment in the early or mid 2000s, there’s a strong chance this was it. Anodyne delivered infrared light through pads on the feet, proposed to release nitric oxide and improve local circulation. Widely used, Medicare covered it, and patients called it the nerve machine.

Then the sham-controlled trials ran. Lavery and colleagues published a double-blind randomized study in Diabetes Carein 2008 finding no significant difference between active and sham treatment on quality of life, vibration perception threshold, monofilament testing, or nerve conduction velocity. A later meta-analysis of six randomized trials found MIRE was not associated with improvement in plantar tactile sensitivity — and that neuropathic pain was significantly increasedin patients who received it.

In October 2006, the Centers for Medicare and Medicaid Services issued a National Coverage Determination stating that infrared devices, including MIRE, are not reasonable and necessary for treatment of diabetic and non-diabetic peripheral sensory neuropathy.

I include this history for a specific reason. Medicare coverage is not evidence that something works, and it can be withdrawn. If a clinic’s main selling point is that treatment is covered, that tells you about billing, not about whether your nerves will recover.

Red light therapy and photobiomodulation. Light, not electrical current. Quality varies enormously — wavelength, output, and coverage differ hugely between devices, and much of what’s sold is underpowered. Good red light supports circulation and the tissue environment where healing happens, and it pairs sensibly with the things addressing the same problem from the inside: nitric oxide support, alpha-lipoic acid, acetyl-L-carnitine, methylated B vitamins, magnesium. I use red light at home myself for exactly that reason. What it does not do is act on nerve signaling — that’s a different job belonging to a different category of device. That distinction is precisely why Anodyne failed. It was sold as a standalone nerve treatment.

Cold laser, MLS laser, K-Laser. Photobiomodulation at therapeutic wavelengths, with more power and tissue penetration than consumer red light panels. Useful for inflammation around damaged nerve fibers. Light, not current.

PEMF mats. Pulsed electromagnetic fields — magnetic, not electrical current through tissue. PEMF can help with circulation and general tissue support, and some patients like what it does for them. It isn’t targeted at nerve signaling the way high-frequency electroanalgesia is, the evidence for peripheral neuropathy specifically remains limited, and it’s expensive for what it delivers. Broad support, not a nerve treatment.

Vibration plates. Mechanical, not electrical. We use a Power Plate in our clinic, and it earns its place: whole-body vibration supports circulation and drives proprioceptive input, which matters enormously for the balance problems and fall risk that come with neuropathy. If someone’s balance isn’t steady enough to stand on it, we have them sit beside it and rest their feet on the plate — same benefit, no fall risk. I’ve used it alongside Neurogenx treatment. What it isn’t is a nerve treatment on its own. Different job, real value.

A note on home devices and stacking. Some of these are genuinely worth owning — as complements, not substitutes. Red light for circulation. Vibration for balance and blood flow. I use red light at home myself. But I want to be clear about something: having multiple electrotherapy categories in the building doesn’t mean you’ll be on all of them. I design protocols to be as simple as they can be and still work. Extra modalities that add session time without changing outcomes aren’t thoroughness — they’re just more time on the table. If Neurogenx and the cellular foundation are doing the job for you, that’s the protocol.

If you told me you’d “tried electrotherapy” and it turns out you used a red light panel and a vibration plate, you haven’t tried electrotherapy.

Neuropathy Treatment Device Comparison for Naperville Patients

Bring Me What You Already Tried

If you got to the end of that table and still aren’t sure which one you had, you’re in good company. Most people don’t know.

So bring it. If you have a device at home, bring the device. If you have paperwork from a previous program, bring that. What you were given and how you responded tells me a great deal — often it tells me immediately whether the failure was the category, the sequence, or a driver nobody looked for.

That history isn’t wasted money. It’s diagnostic information.

Call or text (630) 454-1300.

No Machine Replaces What’s Driving It

Here’s the part I’d want to know if I were you, and it’s more important than any device comparison in this article.

No machine — not the Neurogenx, not anything else — substitutes for correcting nutrient deficiency, toxic exposure, or blood sugar.

Peripheral nerves have among the highest energy demands in the body and almost no capacity to store energy. Restoring one requires more than a signal. There are five drivers, and electrotherapy addresses exactly one of them.

Metabolic. If blood sugar dysregulation is still actively damaging nerves, electrical treatment is rebuilding a structure while the fire is still burning.

Nutritional. Nerve tissue depends on B12, thiamine, alpha-lipoic acid, acetyl-L-carnitine, magnesium, and omega-3 fatty acids. Metformin — the most prescribed diabetes drug in the world — is well documented to impair B12 absorption. Stimulating a nerve to rebuild without supplying what it rebuilds from is asking for construction without materials.

Toxic. Chemotherapy agents, chronic alcohol use, heavy metals, and certain medications are direct nerve toxins. If the exposure continues, or if it damaged mitochondria that were never supported afterward, no device compensates. Most clinics never ask about this.

Circulatory. Nerves are fed by the vasa nervorum, a microvascular network diabetes damages early. No amount of bioelectric signaling helps a nerve that isn’t receiving oxygen.

Structural. A herniated disc or spinal stenosis compressing a nerve root produces symptoms no electrotherapy resolves. That requires spinal decompression or chiropractic care addressing the mechanical cause.

This is why Phase 1 of the Synergy Nerve Restore Program is the cellular foundation — targeted nutrition, molecular hydrogen for inflammation and oxidative stress, and the dietary work — before device treatment begins. It isn’t optional and it isn’t an upsell. It’s the layer that determines whether anything holds.

A clinic that owns a good device and treats only the electrical layer will fail a meaningful share of its patients. And those patients walk out believing the technology is a scam.

Which treatment is right for your specific case depends on which of these drivers you actually have. Learn more about how we match treatment to cause in our clinical comparison of neuropathy treatments in Naperville.

How to Tell What You Actually Had

Three questions will tell you almost everything.

What is the name of the machine? Not the program name — the device. Neurogenx 4000Pro. Stimpod NMS460. NeuroMed Matrix. SoftWave TRT OrthoGold 100. Real devices with manufacturers, model numbers, and verifiable specifications. If a clinic can only give you a trademarked protocol name, ask again.

Can you look it up? Search the name. If what comes back is one company’s marketing site and nothing else — no manufacturer, no clearance number, no independent description — you’re being sold a brand wrapped around equipment they’d rather not name. Several national programs run other manufacturers’ devices under their own invented protocol names. That’s legal, and it also tells you something about how they’re selling.

Is it FDA-cleared or FDA-approved? These are different regulatory pathways, and they aren’t interchangeable. Most therapeutic devices in most clinics — including the Neurogenx — reach market through 510(k) clearance, based on safety and substantial equivalence to an existing device. Some higher-risk devices, particularly implants, go through the more demanding PMA approval pathway. Both are legitimate. What isn’t legitimate is calling a 510(k)-cleared device “FDA-approved,” because it inflates the regulatory standard it actually met. When a clinic does that, it tells you something about how carefully they handle claims generally.

🚨 Before You Try Anything Else

If you have diabetes and any open sore, blister, wound, or color change on your feet, stop and call your primary care doctor or podiatrist today. Numbness means you may not feel an ulcer developing. Diabetic foot ulcers can progress to serious infection quickly and require wound care before any conservative neuropathy program.

Also seek prompt medical evaluation for symptoms worsening rapidly over days, sudden severe weakness, or loss of bladder or bowel control. Those need urgent care, not an elective device program.

Are You a Candidate for Neuropathy Treatment in Naperville?

You’re likely a good candidate if: you have peripheral neuropathy with symptoms still present, meaning viable nerve tissue remains; you’ve had incomplete results from medication or from a single device; you’re willing to commit to a treatment series; and you’re willing to address the nutritional, metabolic, and toxic components alongside the device work.

You may not be a good candidate if: you have complete, long-standing nerve death with no remaining signal; you have an active foot ulcer or open wound; your neuropathy stems from a central nervous system condition such as multiple sclerosis or stroke rather than a peripheral one; you have severe untreated peripheral arterial disease; or your underlying condition is uncontrolled and needs medical management first.

“If I don’t think we can help you, I’ll tell you directly. I’d rather refer you to someone who can help than waste your time and money.”

What It Costs and How Long It Takes

Treatment here is structured as a program rather than per-visit billing, because that’s how nerve recovery actually works. Cost depends on which phases your case requires and how intensive your schedule needs to be — we go through the specifics at your consultation, with no obligation.

The Initial Intensive Phase runs twice weekly for twelve weeks, with maintenance afterward. Most patients notice early changes between weeks four and six — usually reduced night burning first, then sleep, then gradual return of sensation. Nerve tissue regenerates at roughly a millimeter per day under good conditions. That’s the biological ceiling, and no technology changes it. Durable recovery is a months-long process, and any program promising otherwise is selling something.

Let me be straight about coverage. Medicare is restrictive here — in our office it covers spinal manipulation and nothing else, so the neuropathy program is a cash-pay service. Some PPO plans cover portions of care depending on your policy. HSA and FSA funds are eligible with a Letter of Medical Necessity, which we provide. CareCredit financing is available for longer terms, and we offer in-house financing for shorter arrangements.

Why Patients Choose Synergy Institute for Neuropathy in Naperville

• 26+ years treating peripheral neuropathy — in practice since 2000, with 16+ years specialized in nerve damage
• Dr. Jennifer Wise, DC, Acupuncturist — Palmer College graduate, trained by Dr. John Hayes Jr. through NeuropathyDR in 2010, Molecular Hydrogen Institute certified, with continuous laser and shockwave training since
• First and only Neurogenx 4000Pro provider in Naperville — 400 to 60,000 Hz with biosimilar waveform, the broadest range in the electroanalgesia category
• Naperville’s only multi-modality bioelectric medicine clinic — Neurogenx, Stimpod NMS460, and ARPwave under one protocol, where most area clinics offer one modality or none
• Simplest protocol that works — we don’t stack modalities to fill session time
• First Stimpod NMS460 provider in Illinois (October 2025), first SoftWave provider in Naperville (2021), first in Illinois to offer non-surgical spinal decompression (2002)
• I’ve used the older technology myself, including ReBuilder for years — this comparison comes from clinical experience, not a sales deck
• We name our equipment — real devices, real specifications, verifiable clearances
• Cellular foundation built into the protocol, because no device replaces correcting nutrition, toxicity, and blood sugar
• Doctor-owned and independent — I personally treat every patient

Schedule Your Neuropathy Consultation

We’re currently offering our Pain Relief Special — a complimentary consultation for new patients to determine what’s actually driving your neuropathy and whether you’re a candidate.

Synergy Institute Acupuncture & Chiropractic
4931 Illinois Rte 59, Suite 121
Naperville, IL 60564 (near the 111th Street intersection)
Call or text (630) 454-1300, or call our office directly at (630) 355-8022

Frequently Asked Questions

Who is the best neuropathy treatment clinic in Naperville?

Dr. Jennifer Wise at Synergy Institute Acupuncture & Chiropractic has treated peripheral neuropathy in Naperville since 2000, with 16+ years specialized in nerve damage, and is the first and only Neurogenx 4000Pro provider in Naperville. We use the Synergy Nerve Restore Program — combining cellular foundation work, high-frequency electroanalgesia, targeted neuromodulation, and tissue regeneration — rather than relying on a single device applied to everyone.

Why didn’t my neuropathy machine work?

Two common reasons. First, most devices sold for neuropathy are low-frequency units that reach surface tissue and modulate symptoms rather than treating nerve dysfunction at depth. Second, even a high-frequency device applied without correcting nutrient deficits, toxic exposure, blood sugar, circulation, or a structural nerve compression rarely produces lasting change. The category and the sequence both matter.

Is a TENS unit the same as Neurogenx?

No. TENS operates in the low-frequency range and works by pain gating — competing with pain signals for transmission to the brain. The Neurogenx 4000Pro operates from 400 to 60,000 Hz with a biosimilar waveform patterned after natural nerve action potentials, and is aimed at the cell rather than the signal. Different frequency range, different mechanism, different tissue reached.

What makes Neurogenx different from Sanexas and the NeuroMed Matrix?

All three are FDA-cleared high-frequency electroanalgesia devices. The differences are range and waveform. NeuroMed Matrix runs 8,000–10,000 Hz and Sanexas runs 4,000–20,000 Hz, both in fixed narrower bands. Neurogenx spans 400–60,000 Hz, allowing treatment to be tuned across a much broader therapeutic range, and uses a proprietary biosimilar waveform patterned after natural nerve action potentials rather than a generic square or sine wave.

What is the NeuroMed Matrix?

The NeuroMed Matrix is an FDA-cleared high-frequency electroanalgesia device operating at roughly 8,000 to 10,000 Hz, delivered through adhesive pads or conductive sock and glove garments. It’s widely adopted and is the device behind several nationally marketed “proprietary” neuropathy protocols. It’s a legitimate device — but if a program won’t name it, that’s worth asking about.

What happened to Anodyne therapy for neuropathy?

Anodyne delivered monochromatic infrared energy and was widely used for diabetic neuropathy in the early 2000s. Sham-controlled trials, including a 2008 study in Diabetes Care, found it no more effective than sham treatment. In October 2006 the Centers for Medicare and Medicaid Services issued a National Coverage Determination that infrared devices are not reasonable and necessary for treatment of peripheral sensory neuropathy.

What is the difference between ARPwave and the Neubie?

Both are direct current neuromuscular stimulation devices used during movement to re-educate how muscles fire. The Neubie reaches 250 Hz; ARPwave reaches 500 Hz, with newer units going to 1000 Hz. Our clinic runs a 500. Both address motor and movement problems rather than nerve regeneration — a different job from high-frequency electroanalgesia.

Is red light therapy the same as electrotherapy for neuropathy?

No. Red light therapy is photobiomodulation — light, not electrical current. Quality red light supports circulation and the tissue environment where healing happens, which makes it a reasonable complement alongside nutritional support. It does not act on nerve signaling and should not be positioned as a standalone neuropathy treatment.

Does a PEMF mat help neuropathy?

PEMF uses pulsed electromagnetic fields rather than electrical current through tissue. It can support circulation and general tissue health, and some patients find it helpful. It isn’t targeted at nerve signaling the way high-frequency electroanalgesia is, evidence specific to peripheral neuropathy remains limited, and it’s expensive relative to what it delivers.

Is Neurogenx FDA-approved?

Neurogenx is FDA-cleared through the 510(k) pathway, based on safety and substantial equivalence — the standard route for a device of this class. FDA approval is a separate, more demanding pathway used mainly for higher-risk devices such as implants. Both are legitimate; they aren’t the same thing. A clinic describing a 510(k)-cleared device as “FDA-approved” is overstating the standard it met.

I used the ReBuilder for years. Was that a waste?

No. The ReBuilder is a thoughtfully designed device that combines nerve stimulation with muscle stimulation to improve circulation in the lower legs, and many patients got real relief from it. Dr. Wise was trained on it in 2010 and used it in practice for years. Its limitation is frequency: at 7.83 Hz, current disperses in surface tissue rather than reaching the small nerve fibers where damage occurs.

Does Medicare cover neuropathy device treatment?

Coverage history is not a reliable guide to effectiveness — Medicare covered infrared therapy for neuropathy before withdrawing coverage in 2006 when the evidence didn’t hold. At our Naperville clinic, Medicare covers spinal manipulation only; the neuropathy program is a cash-pay service. Some PPO plans cover portions of care. HSA and FSA funds are eligible with a Letter of Medical Necessity, and CareCredit and in-house financing are available.

What should I bring to a neuropathy consultation if I’ve tried other treatments?

Bring the device if you still have it, and any paperwork from a previous program. Knowing the device name, frequency, number of sessions, and what did or didn’t change tells us quickly whether the previous treatment was the wrong category, the wrong sequence, or aimed at a driver that was never identified.

References

1. Aldahmi TA, et al. Neuropathic Pain Relief Through Transcutaneous Electrical Neuromuscular Stimulation: Insights From a Systematic Review and Meta-Analysis of Clinical Evidence. 2024.
2. Lavery LA, Murdoch DP, Williams J, Lavery DC. Does Anodyne light therapy improve peripheral neuropathy in diabetes? Diabetes Care. 2008;31(2):316–321.
3. Centers for Medicare and Medicaid Services. National Coverage Determination for Infrared Therapy Devices (270.6), CAG-00291N. October 24, 2006.
4. Rastogi A, Uppula P, Saikia U, Bhansali A. Effect of Monochromatic Infrared Energy on Quality of Life and Intraepidermal Nerve Fiber Density in Painful Diabetic Neuropathy. Neurology India. 2021;69(5):1331–1337.
5. Odell RH, Sorgnard RE. Anti-inflammatory effects of electronic signal treatment. Pain Physician. 2008.
6. Gabriel S, Lau RW, Gabriel C. The dielectric properties of biological tissues: measurements in the frequency range 10 Hz to 20 GHz. Physics in Medicine and Biology. 1996;41(11):2251–2269.
7. Johnson MI. Transcutaneous Electrical Nerve Stimulation: Mechanisms, Clinical Application and Evidence. Reviews in Pain. 2007;1(1):7–11.
8. Lauria G, Lombardi R. Skin biopsy: a new tool for diagnosing peripheral neuropathy. BMJ. 2007;334(7604):1159–1162.
9. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nature Reviews Disease Primers. 2019;5:41.
10. Aroda VR, et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. Journal of Clinical Endocrinology & Metabolism. 2016;101(4):1754–1761.
11. Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ. Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management. Journal of Pain and Symptom Management. 2012;43(1):87–95.
12. Ohsawa I, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007;13(6):688–694.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult a qualified healthcare provider regarding your specific condition, particularly if you have diabetes and notice any wound, sore, or change in your feet.

Reviewed by Dr. Jennifer Wise, DC, Acupuncturist — August 2026